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Mechanical stretch induced 
transcriptomic profiles in cardiac 
myocytes
Jaana Rysä  1,2, Heikki Tokola2,3 & Heikki Ruskoaho  2,4
Mechanical forces are able to activate hypertrophic growth of cardiomyocytes in the overloaded 
myocardium. However, the transcriptional profiles triggered by mechanical stretch in cardiac myocytes 
are not fully understood. Here, we performed the first genome-wide time series study of gene 
expression changes in stretched cultured neonatal rat ventricular myocytes (NRVM)s, resulting in 205, 
579, 737, 621, and 1542 differentially expressed (>2-fold, P < 0.05) genes in response to 1, 4, 12, 24, 
and 48 hours of cyclic mechanical stretch. We used Ingenuity Pathway Analysis to predict functional 
pathways and upstream regulators of differentially expressed genes in order to identify regulatory 
networks that may lead to mechanical stretch induced hypertrophic growth of cardiomyocytes. We 
also performed micro (miRNA) expression profiling of stretched NRVMs, and identified that a total of 
8 and 87 miRNAs were significantly (P < 0.05) altered by 1–12 and 24–48 hours of mechanical stretch, 
respectively. Finally, through integration of miRNA and mRNA data, we predicted the miRNAs that 
regulate mRNAs potentially leading to the hypertrophic growth induced by mechanical stretch. 
These analyses predicted nuclear factor-like 2 (Nrf2) and interferon regulatory transcription factors 
as well as the let-7 family of miRNAs as playing roles in the regulation of stretch-regulated genes in 
cardiomyocytes.
Cardiac hypertrophy provides an adaptive mechanism to maintain cardiac output in response to increased work-
load, such as occurs in diseases such as chronic hypertension or myocardial infarction. In the early stages of 
pathological hypertrophy, changes in cardiac structure compensate for the increased load, whereas in later stages, 
excessive hypertrophic growth results in decompensation and heart failure1,2. As cardiac myocytes are generally 
considered to be terminally differentiated cells3, cardiac hypertrophy has been considered to involve an increase 
in the size of individual cardiomyocytes. Hypertrophy is associated with alterations in the structure of the heart 
referred to as myocardial remodeling; in the late-phase, this includes increased extracellular matrix (ECM) depo-
sition, perturbations of cellular calcium homeostasis and an increased rate of cardiac myocyte apoptosis4,5.
Hypertrophic growth of cardiac myocytes is triggered by mechanical stimuli as well as the neurohumoral 
activation produced by cardiac overload. At the level of individual cardiac myocytes, the hypertrophic response 
is characterized not only by an increase in cell size, but also by an accumulation in the total protein, enhanced 
sarcomeric reorganization and complex changes in cardiac gene expression1,6. The early genetic response to 
hypertrophic stimulation involves the rapid and transient activation of the so-called immediate-early genes such 
as proto-oncogenes (c-fos, c-myc, c-jun and Egr-1) independently of new protein synthesis7 and a heat shock 
protein-708. For example, the activation of c-fos mRNA levels in response to mechanical stretch in cardiomyo-
cytes has been shown to occur within 15 minutes and then to decline to undetectable levels after 4 h9. Translated 
protein products of the c-fos and c-jun genes play an important role as transcriptional regulators of cardiac gene 
expression10. This is followed by an upregulation of fetal genes, initially B-type natriuretic peptide (BNP), and 
later reactivation of atrial natriuretic peptide (ANP) gene as well as β-myosin heavy chain (β-MHC) and skeletal 
muscle α-actin (skαA) contractile protein isoforms11.
Both cellular components and extracellular structures have been shown to contribute to the transfer of 
mechanical stretch signals into the nucleus. These mechanotransduction elements include ECM, cell-cell 
1School of Pharmacy, University of Eastern Finland, Kuopio, Finland. 2Research Unit of Biomedicine, Pharmacology 
and Toxicology, University of Oulu, Oulu, Finland. 3Department of Pathology, Cancer Research and Translational 
Medicine Research Unit, University of Oulu and Oulu University Hospital, Oulu, Finland. 4Drug Research Program, 
Division of Pharmacology and Pharmacotherapy, University of Helsinki, Helsinki, Finland. Correspondence and 
requests for materials should be addressed to J.R. (email: jaana.rysa@uef.fi)
Received: 13 December 2017
Accepted: 6 March 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCiEnTiFiC RepoRtS |  (2018) 8:4733  | DOI:10.1038/s41598-018-23042-w
adhesions, ECM–sensing receptors including integrins, cytoskeletal filaments, nuclear scaffolds, and ion chan-
nels. Subsequently, mechanical stretch is able to activate a complex network of parallel downstream signal trans-
duction pathways as well as elevating autocrine production and the release of growth factors, resulting in de novo 
synthesis of immediate response genes and total protein synthesis12,13. It is still poorly understood whether stretch 
itself is the direct trigger for the growth process, and furthermore, the mechanisms of altered gene expression are 
still largely unknown.
Numerous animal models, especially genetically modified animals, have been widely used to elucidate the 
molecular mechanisms of cardiac hypertrophy14,15. Moreover, many in vitro and ex vivo models have been devel-
oped for investigating the different components of hemodynamic overload16. However, cell culturing is virtually 
the only approach that makes it possible to study individually the different cell types and molecular characteristics 
of distinctive components of cardiac overload (e.g. mechanical stretch, neurohumoral factors) under experimen-
tally controlled conditions for periods long enough to detect changes in gene expression and morphology17. The 
majority of cell culture studies have been conducted with primary neonatal rat ventricular myocytes (NRVMs)17–19. 
Although gene expression changes are crucial for the development of cardiac hypertrophy, virtually nothing is 
known about genome-wide gene expression response of stretched cardiac myocytes. As far as we are aware, the 
gene expression patterns have been examined only at one timepoint, 24 hours after the start of biaxial stretching 
in NRVMs20 or cyclic stretching in cardiac myocytes21. In addition, there is one report of a DNA microarray anal-
ysis of stretched neonatal rat cardiac fibroblasts in response to 24 hours of stretching21.
Here, we characterized the comprehensive time course of mechanical stretch activated hypertrophic gene 
expression response in a well-established in vitro model of cultured NRVMs. In addition, we analyzed the func-
tional interaction networks among differentially expressed genes by using Ingenuity pathway analysis (IPA). 
Finally, we identified mechanical stretch regulated microRNAs (miRNAs) in cardiomyocytes and elucidated their 
stretch regulated target genes. We believe that this is the first study to fully cover the genome-wide transcriptomic 
changes in cultured cardiac myocytes from the triggering of the mechanical stretch and to the subsequent stretch-
ing of the cells for two days.
Results
Mechanical stretch induced cardiac hypertrophic gene program. We validated the in vitro mechan-
ical stretch model of cultured NRVMs by measuring gene expression levels of immediately early gene c-fos, as well 
as BNP and ANP mRNA levels, which represent genetic hallmarks of the stretch induced cardiac hypertrophic 
program22–24. In agreement with previous studies, the highest induction of c-fos mRNA levels was detected after 
one hour of mechanical stretch (2.4-fold, P < 0.01) (Supplementary Table S1), whereas cyclic mechanical stretch 
elevated ANP and BNP mRNA levels significantly after 1 hour, peaking at 24 to 48 hours (5.6 ± 1.0-fold, P < 0.01 
and 3.6 ± 0.4, P < 0.001, respectively) (Supplementary Table S2).
Enhanced kinase activation by mechanical stretch in NRVMs. Previous studies have shown that 
mechanical stretch activates protein kinase C (PKC)-pathway and all three main mitogen activated protein kinase 
(MAPK) pathways; extracellular signal regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 MAPK 
pathways8,13,24,25. Consistently with previous studies, mechanical stretch evoked significant activation of p38 
MAPK, ERK and JNK–pathways as shown by western blot analyses (Supplementary Fig. 1A). The ratio of phos-
phorylated to total p38 MAPK increased transiently, peaking at 4 hours (2.4-fold, P < 0.001) and returning near 
to basal levels by 24 hours (Supplementary Fig. 1A). When compared with p38 MAPK, the activation of ERK and 
JNK was more rapid, peaking already at 15 to 30 minutes (3.3-fold, P < 0.01, and 3.1-fold, P < 0.001, respectively) 
(Supplementary Fig. 1B,C).
Differentially expressed genes after mechanical stretching. We evaluated gene expression profiles 
at 1, 4, 12, 24, and 48 hours after the start of cyclic mechanical stretching in order to identify those genes that were 
regulated by mechanical load in cardiac myocytes in vitro. We confirmed selected microarray results by their 
comparison with the corresponding mRNA levels obtained by Northern blot analysis or real-time quantitative 
RT-PCR. As shown in Supplementary Tables S1 and S2, similar fold changes in mRNA levels were observed as 
measured by both DNA microarray and Northern/RT-PCR.
The gene expression profiling of stretched NRVMs identified altogether 76, 113, 140, 136, and 558 different 
transcripts that were differentially expressed (2-fold, p < 0.05) in response to mechanical stretching of 1, 4, 12, 24, 
and 48 hours, respectively (Fig. 1A). The numbers of differentially expressed genes were notably higher when we 
compared 1.5-fold differences in gene expression levels of stretched myocytes with those of unstretched control 
cells (Fig. 1B). According to these selection criteria, our analysis identified 205, 579, 737, 621, and 1542 differ-
entially expressed genes in response to 1, 4, 12, 24, and 48 hours of mechanical stretching, respectively. After 
one hour, more genes were upregulated than were downregulated, which was followed by approximately similar 
numbers of up- and down-regulated genes in response to 4, 12, and 24 hours of stretching. Instead, at 48 hours 
after the start of the stretch, more genes were repressed than upregulated.
Venn diagrams were produced to describe the overlap of significantly up- or down-regulated genes in stretched 
myocytes (Fig. 1C–J). At earlier timepoints (1–12 hours), more timepoint specific differences were observed in 
the expression patterns of differentially expressed genes (Fig. 1C–F), whereas in response to 24 and 48 hours of 
stretch (Fig. 1G–J), the majority of differentially expressed genes in 24 hours were up- or down-regulated also 
after 48 hours of mechanical stretching. These trends in the amount of differentially expressed genes were essen-
tially similar whether we evaluated 2-fold (Fig. 1C,D,G,H) or 1.5-fold (Fig. 1E,F,I,J) differences in expression 
levels of stretched cells in comparison to unstretched control cells. The ten most up- and down-regulated genes 
in stretched myocytes at each time point are shown in Fig. 2. The total lists of differentially expressed genes by 
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mechanical stretch in NRVMs are provided in Supplementary Dataset 1 and the data with normalized values in 
Supplementary Dataset 2.
Functional and pathway analysis of differentially expressed genes. By using the datasets of dif-
ferentially expressed genes in response to mechanical stretch at each timepoint, it was possible to conduct an IPA 
functional analysis and generate predictions for significantly increased or decreased (z-score >2 or <−2, respec-
tively) activity in various cellular processes. The most evidently altered biological functions are summarized in 
Fig. 3. In response to 1–24 hours of mechanical stretch, more biological pathways were activated than inactivated, 
and the activated functions were mostly related to cellular growth and proliferation whereas cell death and necro-
sis were among the functions predicted as being decreased by IPA-analysis (Fig. 3A–D). At 48 hours, more biolog-
ical pathways were inactivated than activated, although pathways related to cell growth remained active (Fig. 3E). 
All significantly altered biological pathways are described in Supplementary Dataset 3.
Canonical pathways. Next, specific changes in canonical biological pathways related to differentially 
expressed genes at each timepoint (Supplementary Dataset 1) were examined (Fig. 4). Our canonical pathway 
analysis revealed that in the acute phase, all of the significantly modulated pathways, such as the proinflammatory 
interleukin-1 (IL-6) and IL-8 signaling pathways, had become activated. In the late phase response (48 hours), the 
majority of signaling pathways were repressed, including the Nf-kB and endothelial nitric oxide synthase (eNOS) 
signaling pathways. The nuclear factor-like 2 (Nrf2) mediated oxidative stress response signaling was the pathway 
having the highest activation (a −log [p-value] and an absolute z-score >2) in stretched myocytes during the 
acute phase (i.e. at 12 hours), whereas in the late phase, it was lipopolysaccharide (LPS)/IL-1 mediated inhibition 
of retinoid X receptor (RXR) function –signaling (at 48 hours). The transcriptional response regulated by Nrf2 in 
the nucleus of stretched NRVMs is shown in Fig. 5 with the whole pathway illustrated in Supplementary Fig. 2. 
LPS/IL-1 mediated inhibition of RXR function –signaling pathway is shown in Supplementary Fig. 3. In addi-
tion to known pathobiological pathways, it is likely that other molecular mechanisms are involved in mediating 
hypertrophic growth of cardiomyocytes. IPA-analysis was used to determine the biological relationships among 
the differentially expressed genes at each timepoint. The top five molecular networks underlying stretch-activated 
Figure 1. Differentially expressed genes in stretched neonatal rat ventricular myocytes. (A,B) Numbers 
of differentially expressed genes in response to 1–48 hours of cyclic mechanical stretch in cultured cardiac 
myocytes with (A) 2-fold difference and (B) 1.5 fold difference. Black columns, upregulated genes; white 
columns downregulated genes, n = 5 in all groups. (C–I) Venn diagrams indicate the overlap of the genes that 
were significantly (C) upregulated (>2-fold) or (D) downregulated (<2-fold) and (E) upregulated (>1.5-fold) 
or (F) downregulated (<1.5-fold) after 1, 4 or 12 hours of stretch as compared to controls. A Venn diagram 
indicating the overlap of the genes that were significantly (G) upregulated (>2-fold) or (H) downregulated (<2-
fold) and (I) upregulated (>1.5-fold) or (J) downregulated (<1.5-fold) after 24 or 48 hours of stretch compared 
to controls.
www.nature.com/scientificreports/
4SCiEnTiFiC RepoRtS |  (2018) 8:4733  | DOI:10.1038/s41598-018-23042-w
gene expression changes at each timepoint based on Fisher’s exact test and full annotations for genes and mole-
cules in these networks are shown in Supplementary File 2.
Upstream analysis. Next we performed an upstream analysis to identify potential upstream regulators that 
could explain the observed changes in gene expression patterns in stretched myocytes. The top five upstream 
regulators that were predicted to be activated or inhibited in stretched NRVMs are shown in Fig. 6. In the acute 
phase, tumor necrosis factor (TNF), epidermal growth factor (EGF) and phorbol myristate acetate (PMA, an 
activator of PKC) were the most relevant upstream regulators predicted to be in an activated state at several 
timepoints (Fig. 6A–E). The top upstream regulators predicted to be inhibited at the 1 hour timepoint included 
five kinase inhibitors (LY294002, Phosphatidylinositol-4,5-bisphosphate 3-kinase [P13K] inhibitor; PD98059, 
MAPK of ERK kinase [MEK]-inhibitor, SB203580, MAPK-inhibitor, SP600125, JNK-inhibitor; U0126, MEK1 
and MEK2 inhibitor), and many of them were among the top predicted inhibited regulators throughout the 
acute phase (until 12 hours of stretching). In the late phase, several transcription factors were among the pre-
dicted upstream regulators: activated regulators included cAMP responsive element binding protein 1 (CREB1) 
and tripartite Motif-Containing Protein 24 (TRIM24); the inhibited regulators included interferon (IFN) reg-
ulatory transcription factor (IRF) family (IRF)7, IRF3, and Peroxisome proliferator-activated receptor gamma 
coactivator 1α (PPARGC1A) (Fig. 6D–E). All significant upstream regulators at each timepoint are detailed in 
Supplementary Dataset 4.
Differentially expressed miRNAs in stretched cardiac myocytes. MicroRNA expression profiling 
was performed by using commercial miRCURY LNATM Arrays (v.10.0) to determine differentially expressed 
miRNA molecules in stretched NRVMs. The analysis indicated that a total of 8 and 87 miRNAs had been signif-
icantly altered (P < 0.05) in samples of 1–12 h and 24–48 h, respectively, when compared to unstretched control 
samples (n = 3 in all groups, except n = 2 in samples from the 12 h timepoint). The heat map diagrams show the 
results of the two-way unsupervised hierarchical clustering of miRNAs and samples of 1–12 h (P < 0.05; Fig. 7A 
and Supplementary Dataset 5) and 24–48 h (P < 0.001; Fig. 7B and Supplementary Dataset 5). In response to 
1 hour of mechanical stretching, only one miRNA, rno-miR-130b showed differential expression compared to 
controls (P < 0.05), whereas 8 miRNAs (rno-miR-322, rno-let-7f, rno-miR-103, rno-miR-126, rno-miR-494, 
rno-miR-126*, rno-miR-130b, rno-miR-195; P < 0.05) were dysregulated in response to 4 hours of stretch 
(Supplemental Dataset 5). At a later time point i.e. 12 hours of mechanical stretching, only rno-miR-126 exhib-
ited any significantly (P < 0.05) dysregulated expression in response to unstretched cells. In the response to 24 
Figure 2. The ten most up- and down-regulated genes in stretched myocytes at 1–48 hours after the initiation 
of the mechanical stretch. Fold change indicates statistically significant (P < 0.05) difference in gene expression 
between stretched and unstretched neonatal rat ventricular myocytes. Green columns, downregulated genes; 
red columns upregulated genes.
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and 48 hours of stretching, 51 and 63 miRNAs were significantly (P < 0.05) differentially expressed in stretched 
myocytes compared to controls (Supplementary Dataset 5). At 24 hours, five miRNAs (rno-miR-214, rno-miR-
99a, rno-miR-363*, rno-miR-100 and rno-miR-340–5p) and at 48 hrs 6 miRNAs (rno-miR-34b, rno-miR-500, 
rno-miR-24-1*, rno-miR-29b, rno-miR-199a-3p, rno-let-7a) showed the most prominent dysregulation 
(P < 0.001) (Fig. 7B).
Integration of miRNA and mRNA expression data. In an attempt to characterize potential 
mRNA-miRNA interactions that regulate mechanical stretch activated hypertrophic response in NRVMs, we 
performed a correlation analysis between dysregulated miRNAs and the mRNA expression data sets. We used the 
microRNA Target Filter of IPA software to reveal putative relationships between significantly dysregulated miR-
NAs in each timepoint (Supplementary Dataset 5) and the corresponding stretch-regulated genes at the same or 
later timepoints (Supplementary Dataset 1). We applied this approach to all significantly up- or down-regulated 
miRNAs at each time point as follows: For the only dysregulated miRNA at 1 hours (rno-miR-130b), we searched 
through the IPA database to identify potential mRNA targets among stretch-regulated genes in response to 1, 
4, and 12 hours of stretching. In response to 4 hours of mechanical stretch, rno-miR-322, let-7f, miR-103, miR-
126, miR-494, miR-126*, miR-130b and miR-195 were significantly dysregulated (Fig. 7A and Supplementary 
Dataset 5), so we sought potential mRNA targets for these dysregulated miRNAs among the stretch-regulated 
genes in 4 and 12 hours timepoints. We conducted a similar comparison for each dysregulated miRNAs at each 
time point. The results of these analysis are shown in Supplementary Dataset 5. Based on this IPA interroga-
tion analysis, let-7f was considered to have the highest amount of experimentally validated targets among the 
stretch-activated genes in response to 4 and 12 hours of stretch (7 and 11 mRNAs, respectively) (Fig. 8A). With 
Figure 3. Functional analysis of differentially expressed genes in stretched neonatal rat ventricular myocytes. 
Differentially expressed genes (1.5-fold upregulation or downregulation compared to controls; P < 0.05) were 
used in the functional analysis in the IPA-software. A positive or negative z-score value (columns) indicates 
that a function would be predicted to be either increased (A) or decreased (B) in stretched myocytes. Only 
those functional annotations that obtained a significant regulation z-score (>2) are presented. The p-value (red 
dots) reflects the likelihood that the association between a set of genes in our dataset and a related biological 
function would be significant [p-value < 0.05 (i.e., −log10 ≥ 1.3), Fisher’s Exact test]. A maximum 10 genes per 
activation/inactivation-route and P < 1.00E-9 are shown per timepoint. Numbers of differentially expressed 
genes in each functional class are shown in parentheses.
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respect to the miRNAs that were differentially regulated in response to 24 hours of stretch, let-7c had 8 mRNA 
targets of stretch-regulated genes at 24 hours, and 18 mRNA targets among stretch-regulated genes of 48 hours 
(Fig. 8B). In contrast, the dysregulated miRNA, let-7a, had 18 target mRNAs among the stretch-regulated genes 
at the 48 hours timepoint (Fig. 8C).
Discussion
Cell culture is virtually the only possible approach for elucidating separately the biochemical and molecular 
characteristics of different components of cardiac overload under experimentally controlled conditions for long 
enough periods that one can detect changes in morphology and gene expression17. The most common in vitro 
model of hypertrophy employs primary cultures of neonatal rat ventricular cardiomyocytes19. The use of immor-
tal, transformed cells has limitations since the transformation process changes the basic properties of cardiomy-
ocytes and these might well be very relevant to cardiac biology26; the utilization of neonatal mouse ventricular 
cell cultures is limited because a phenotypic change occurs in which the cells develop autonomous hypertro-
phy27. Here, we performed the first genome-wide time series study of mechanical stretch induced gene expression 
changes in cardiomyocytes. We also analyzed temporal microRNA expression patterns in stretched NRVMs, and 
conducted an IPA analysis to predict functional pathways and upstream regulators of differentially expressed 
genes in order to identify regulatory networks that may lead to mechanical stretch induced hypertrophic growth 
of cardiomyocytes.
Our analysis identified many novel mechanical stretch responsive genes in cardiomyocytes. For example, we 
and others have subsequently revealed activating transcription factor 328, bone morphogenetic protein 229, regen-
erating islet-derived 3γ30, dyxin/LMCD131,32, Fn14 (or TNFrsf12a)33,34, Wdr1235, myeloid leukemia factor-136, 
Myomasp/LRRC3937 and phosphatase and actin regulator 1 (PHACTR1)38 to be a part of stretch activated hyper-
trophic gene program in NRVMs. We validated the reliability of our data by undertaking a DNA microarray 
analysis; this identified well-established changes of hypertrophic gene expression programme in mechanically 
stretched cardiomyocytes. In agreement with previous studies39, the increased expressions of several immedi-
ate early genes such as the fos family (FosB, c-fos, fra-1), JunB, c-myc, Egr-1 and nur77 were seen already after 
1 hour of mechanical stretch. Upregulated gene expression of ANP40 as well as the two growth factors, TGFβ1 and 
TGFβ213, observed in this study, are also well recognized transcriptional changes occurring during the develop-
ment of cardiac hypertrophy. Moreover, there were blunted expressions of muscle creatine kinase (creatine kinase, 
M-type, CKM) and pyruvate dehydrokinase 4 (PDK4) and myoglobin gene expression, reflecting a switch in car-
diac substrate selection from fatty acid to glucose utilization, a phenomenon associated with altered metabolism 
of the heart in cardiac hypertrophy and failure41,42.
There were distinct canonical pathways that were affected in the acute and late phase of mechanical stretch 
induced hypertrophic response in NRVMs. Nrf2-mediated oxidative stress response –signaling was the most 
significantly induced canonical pathway in response to mechanical stretch in the acute phase. Nrf2 activation 
has been shown to reduce myocardial infarct size and cardiac hypertrophy in mice exposed to myocardial infarc-
tion and pressure overload, respectively43,44. In cultured cells, Nrf2 conferred protection against increased ROS 
production and growth of NRVMs and cardiac fibroblasts in response to hypertrophic stimuli44. Our pathway 
analysis identified several well-known members of Nrf2 antioxidant signaling in cardiac hypertrophy, such as 
glutamate cysteine ligase subunits (GCLM and GCLC) and glutathione-disulfide reductase (GSR)45,46, but we also 
detected several Nrf2 targets not previously associated with myocyte hypertrophy, including flavin-containing 
Figure 4. Significant canonical pathways associated with differentially expressed genes in stretched neonatal 
ventricular myocytes. Ingenuity pathway analysis showing the canonical pathways that were most significant 
in the data sets of differentially expressed genes after (A) 1–12 and (B) 24–48 hours of mechanical stretch in 
cardiac myocytes. The entries that have a −log (p-value) greater than 1.3 and an absolute z-score value greater 
than 2 are displayed. Colors of the bars in the chart indicate their activation z-scores: orange, overall increase in 
the activity of the pathway; blue, decrease in activity. The intensity of the color indicates the degree of increase 
or decrease.
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monooxygenase 1 (FMO1), ferritin light chain (FTL) and aflatoxin B1-aldehyde reductase (AFAR/AKR7A2). 
In the late phase, the majority of the significantly altered pathways were downregulated including Nf-kB, eNOS 
and LPS/IL-1 mediated inhibition of RXR function signaling pathways. The interactions between dysregulated 
genes were further elucidated using networks analysis. Well-established transcriptional regulators of hypertrophic 
gene response such as MYC proto-oncogene7 and TGFβ113 were central regulator molecules in many of these 
networks.
Our upstream regulator analysis highlighted the importance of mitogen-activated protein kinases as regu-
lators of the hypertrophic gene response. We demonstrated that mechanical stretch activates all three MAPKs 
(ERK, JNK and p38 MAPK), and in the IPA analysis, MEK, MAPK, JNK, MEK1 and MEK2 inhibitors were 
Figure 5. NRF2-mediated oxidative stress response –signaling in the nucleus. Significant canonical pathways 
associated with differentially expressed genes in response to 12 hours of mechanical stretch in neonatal rat 
ventricular myocytes are shown. Up- and down-regulated genes are displayed in red and green, respectively. The 
intensity of the color indicates the degree of up-regulation or downregulation. Genes are represented as various 
shapes that represent the functional class of the gene product. Full annotations for genes and molecules in this 
canonical pathway and whole figure of this canonical pathway are provided in Supplementary Datafile 1and 
Fig. S2, respectively.
www.nature.com/scientificreports/
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Figure 6. Upstream analysis of mechanical stretch regulated genes. The top five upstream regulators that were 
predicted to be activated and inhibited in response to (A) 1 hour, (B) 4 hours (C), 12 hours (D), 24 hours and (E) 
48 hours of mechanical stretch in neonatal rat ventricular myocytes are shown. Z-scores ≥2 or ≤−2 indicate 
that the upstream regulator was predicted to be activated or inhibited, respectively. The p-value (red dots) 
calculated by a Fisher’s Exact Test was used to determine the significance of the overlap [p-value < 0.05 (i.e., 
−log10 ≥ 1.3) between the regulator and stretch-responsive genes. Only functional annotations that obtained 
a significant regulation z-score (>2) are presented. CREB1, cAMP-responsive element binding protein 1; LPS, 
lipopolysaccharide; EGF, epidermal growth factor; IFNB1, interferon beta 1; IRF3, interferon regulatory factor 
3; IRF7, interferon regulatory factor 7; PDGF-BB, platelet-derived growth factor BB-isoform; PMA, phorbol 
myristate acetate (activator of protein kinase C, PKC); NAC, N-acetyl-L-cysteine; NFE2L2, NRF2 transcription 
factor; TGFβ1, transforming Growth Factor β1, TNF, tumor necrosis factor; TRIM24, tripartite motif-
containing 24. The targets of the inhibitors are LY294002, P13K inhibitor; PD98059, MEK-inhibitor, SB203580, 
MAPK-inhibitor, SP600125, JNK-inhibitor; U0126, MEK1 and MEK2 inhibitor.
www.nature.com/scientificreports/
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found among the predicted inhibited upstream regulators at 1, 4, and 48 hours after the start of mechanical 
stretch, reflecting a multiple peak activation of these kinases11. In addition, TNF and the PKC activator PMA, 
well-known inducers of hypertrophic gene expression47,48, were among the anticipated activated upstream regula-
tors12,49. Another novel finding was that two members of IRF family of transcription factors, IRF3 and IRF7 were 
among the top five predicted inhibited upstream regulators at 24 hours, and IRF7 also at 48 hours. IRF3 and IRF7 
have been reported to act as negative regulators of pathological cardiac hypertrophy by inhibiting ERK1/250 and 
nuclear factor-κB signaling51, respectively, although in another study, IRF3 was claimed to regulate cardiac fibro-
sis but not hypertrophy in mice subjected to angiotensin II-induced hypertension52. IRF3 and IRF7 have a role 
in regulating the transcriptional activity of IFNα and IFNβ53,54, i.e. these are other members of the IFN-signaling 
pathway that were among activated upstream regulators in response to 48 hours of stretching. Binding of IFNβ to 
its receptor is known to activate the JAK-STAT signaling pathway that has a significant role also in controlling the 
expression of hypertrophic gene response11,55. Interestingly, three other members of the IRF-family, IRF1, IRF4 
and IRF9, have also been shown to regulate pathological cardiac hypertrophy56–58, making this family of tran-
scription factors a potentially important regulatory mechanism mediating the load responsive genetic response 
in cardiac hypertrophy.
Our study is the first to identify temporal miRNA expression profiles in response to mechanical stretch in 
cardiac myocytes. MicroRNA profiling identified several miRNAs that have been previously associated with car-
diac hypertrophy such as miR-214, miR-23b, miR-15b, rno-miR-26b, rno-miR-221, rno-miR-222, rno-miR-10759, 
miR-23a, miR-208, rno-miR-133b, miR-19a and mi-r133a60. We integrated miRNA and gene expression profiles 
and by using miRNA target prediction program of IPA software, we could identify miRNAs that were highly 
correlated with differentially expressed predicted gene targets. In our miRNA-analysis, let-7a, let 7c and let-7f 
had the greatest amount of experimentally verified target mRNAs among the dysregulated genes supporting the 
role of Let-7 family of miRNAs as a putatively important regulator of cardiac hypertrophic response through their 
gene target59. At present, little is known about the role of Let-7 family of miRNAs in stretched cardiomyocytes but 
analyses of mechanosensitive miRNAs associated with muscular dystrophies indicated that the let-7 family was 
dysregulated in mice with muscular dystrophies with myositis (mdm-mice)61.
Although we characterized the mechanical stretch regulated gene response in cardiomyocytes, the in vivo 
mechanical load affects also other cell types present in the heart e.g. connective tissue cells and vascular cells. 
The important role of MAPKs converting mechanically induced signals into physiological responses has been 
widely established in several cell types, including fibroblasts62, endothelial cells63 and vascular smooth muscle 
cells64. Similarly, the role of proto-oncogenes in the stretch-response has been characterized in several cell types 
in addition to cardiac myocytes64–66. With respect to the novel potential regulators identifed in our study, Nrf2 has 
been shown to exert a protective role against mechanical stretch induced apoptosis in mouse fibroblasts67, and 
mechanical stretch was reported to induce IRF1 binding activity in vascular smooth muscle cells68. In conclusion, 
in addition to cell-type specific factors, there seem to be conserved mechanisms of mechanotransduction.
Figure 7. Differentially expressed miRNAs in stretched neonatal rat ventricular myocytes. The heat map 
diagram shows the results of unsupervised hierarchical clustering of miRNA expression by LNA microarray 
in cardiac myocytes in response to (A) 1, 4 and 12 hrs (P < 0.05) and (B) 24 and 48 hrs (P < 0.001) of 
mechanical stretching (n = 3 in all groups, except n = 2 at 1-hour time point). The clustering was performed 
on log2(Hy5/Hy3) ratios which passed the filtering criteria by applying a two-tailed t-test between the control 
and experimental groups. Each row represents a miRNA and each column represents a sample. The miRNA 
clustering tree is shown on the left. The color scale shown at the bottom illustrates the relative expression level of 
miRNA across the samples: red color, expression level above mean; blue color, expression lower than the mean; 
gray color, signal below background.
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There are certain limitations to our study. We used neonatal ventricular myocytes that were isolated from 
neonatal pups of both sexes. It is noteworthy that although the primary cultures derived from an adult rat heart 
would reflect better the situation in the mature heart, the limitation is that these adult cultured cells either lose 
their morphology or they lose their ability to undergo spontaneous contractions, when cultured under condi-
tions where the rod-shaped morphology is retained69,70. In addition, cardiomyocytes differentiated from human 
induced pluripotent stem cells (hiPSCs) are relatively immature71 but when it becomes possible to culture human 
cells with a mature adult cardiomyocyte phenotype, it would be interesting to reproduce these stretch exper-
iments in conjunction with next generation sequencing techniques since this would provide a more compre-
hensive and unbiased analysis of both coding and non-coding RNAs. Recently, Trexler et al. (2017) observed 
sex-specific differences in gene expression along with functional differences in isolated adult rat ventricu-
lar myocytes (ARVMs)72. Although not analyzed in this study, the mechanical stretch induced gene response 
most probably occurs in a sexually dimorphic manner. Furthermore, we did not confirm the miRNA profiling 
results with another method and all the effects on miRNAs on gene targets are only predicted; the validation of 
miRNA-mRNA regulation in stretched myocytes will have to be the subject of future work. Finally, all the results 
reflect the situation in isolated cardiomyocytes and do not take into account the contribution of other cell types 
in the development of cardiac hypertrophy.
In conclusion, our study reveals temporal gene and miRNA expression profiles in response to mechanical 
stretch in cardiac myocytes and represents a valuable resource of transcriptional responses. In addition, the anal-
ysis of regulatory pathways as well as miRNA-mRNA interactions predict that Nrf2 and IRF transcription factors 
as well as the let-7 family of miRNAs are playing roles in the regulation of mechanical stretch induced gene 
expression response in cardiomyocytes and these may help in elucidating the genes and regulatory pathways 
underlying cardiac hypertrophy.
Figure 8. Differentially expressed targets shared by relevant miRNAs. Putative stretch regulated targets for (A) 
let-7f, (B) let-7c and (C) let-7a were obtained from the IPA-analysis.
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Methods
Cell culture. Neonatal rat ventricular myocytes were prepared from 2–4 day old Sprague-Dawley rats from 
the colony of the Center for Experimental Animals in the University of Oulu as previously described73. The 
experimental design was approved by the Animal Use and Care Committee of the University of Oulu or the 
National Animal Experiment Board and all experiments were performed in accordance with relevant guide-
lines and regulations. Briefly, after digestion of ventricular tissue with collagenase (2 mg/ml), the cell suspension 
was pre-plated for 30–45 minutes in Dulbecco’s modification of Eagle’s medium/Ham’s F12 medium (DMEM/
F12) containing 10% of fetal bovine serum (FBS). The non-attached myocyte-enriched cell fraction was plated 
at a density of 2 × 105/cm2 on flexible bottomed collagen I-coated 6-well elastomere plates (Bioflex, Flexcell 
International Corporation, Hillsborough, NC, USA.), and cultured overnight with DMEM/F12 10% FBS, and 
thereafter in complete serum free medium (CSFM). The cells were exposed for 15 minutes to 48 hours to cyclic 
mechanical stretch as previously described73. Stretch was introduced onto the cells by applying a cyclic vacuum 
suction under the flexible bottomed plates by computer-controlled equipment (Flexercell Strain Unit FX-3000, 
Flexcell). The vacuum varied in two-second cycles at a level sufficient to promote cyclic 10 to 25% elongation of 
the cardiomyocytes at the point of maximal distension of the culture surface. Within each culture, the stretch was 
started stepwise in the experimetal groups and finished simultaneously to avoid the effect of “ageing” of the cells 
in culture. In the microarray analysis, the experiments were carried out in two separate sets, each having their 
own control; I) 1, 4 and 12 hours, and II) 24 and 48 hours of stretch. After the experiments, the cells were washed 
twice with PBS and quickly frozen at −70 °C or lysed in protein lysis buffer.
Protein extraction. For the total protein extracts, the cells were lysed in ice-cold lysis buffer (20 mM 
Tris-HCl, 150 mM NaCl, 1 mM ethylene diaminetetraacetate (EDTA), 1 mM ethylene glycol tetraacetic acid 
(EGTA), 1% (vol/vol) Triton-X100, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na3VO4) 
supplemented with 20 μg/ml leupeptin, 2 μg/ml pepstatin, 20 μg/ml aprotinin, 1 mM phenylmethylsulfonyl flu-
oride (PMSF), 50 mM NaF, 1 mM dithiothreitol (DTT), 6 μg/ml 1-chloro-3-tosylamido-7-phenyl-2-butanone 
(TPCK), and 6 μg/ml L-1-tosylamido-2-phenylethyl chloromethyl ketone (TLCK)). The lysate was cleared by 
10 min centrifugation at +4 °C and the supernatant was transferred into a new tube as the total protein extract. 
The protein concentration of each sample was determined with a colorimetric assay (Bio-Rad Laboratories).
Western Blot Analysis. Samples containing 18–25 µg of total protein (n = 5–6 biological replicates at each 
time point) were boiled in Laemmli buffer, resolved by sodium dodecyl sulphate polyacrylamide gel electropho-
resis (SDS-PAGE), and transferred to Optitran BA-S 85 nitrocellulose membranes (Schleicher & Schuell). The 
membranes were blocked in 5% nonfat milk and then incubated with primary antibody p38 MAPK [#9212], 
p44/42 (ERK1/2) [#9102], Thr202/Tyr204 phosphorylated ERK (p-ERK1/2) [#9106] and SAPK/JNK (JNK1/2) 
[#9252] from Cell Signalling Technology (San Diego, CA, USA); Thr180/Tyr182 phosphorylated p38 MAPK 
(p-p38 MAPK) [AB3828] from Millipore, Thr183/Tyr185 phosphorylated JNK (p-JNK1/2) [sc-6254] from Santa 
Cruz Biotechnology (Santa Cruz, CA, USA) in 0, 5–1% milk in Tris-buffered saline −0.05% Tween 20 over-
night at 4 °C. The antibody concentration in the dilution varied from 1:1000 to 1:2000, depending on the signal 
strength. On the following day, antibody binding was detected with horseradish peroxidase -linked anti-rabbit or 
anti-mouse IgG (Cell Signalling Technology) at a 1:2000 dilution and revealed using ECL Plus™ Western Blotting 
Detection Reagents as described by the manufacturer (GE Healthcare Bio-Sciences Corp. Piscataway, NJ, USA). 
The chemiluminescence was detected using a Fuji LAS-3000 luminescent image analyzer (Fujifilm, Tokyo, Japan) 
and bands were quantified with Quantity One software (Bio-Rad).
Analysis of RNA. Total RNA from cultured myocytes was isolated with TRIzol Reagent according to the 
manufacturer’s protocol (Invitrogen) by using the Phase Lock Gel system (Eppendorf). In the Northern blot 
analyzes, 5 μg of RNA were separated by agarose-formaldehyde gel electrophoresis and transferred to a MAGNA 
nylon membrane (Osmonics Inc.). PCR-amplified probes corresponding to rat genes for BNP and ribosomal 18 S 
RNA and full-length ANP were random prime-labeled with [α32P]dCTP, and the northern blot membranes were 
hybridized and washed as described previously74 and exposed to Phosphor screens (GE Healthcare Life Sciences). 
The signal was detected with Molecular Imager FX Pro Plus (Bio-Rad) equipment and measured using Quantity 
One software. The signals of mRNA were normalized to 18 S in each sample to correct for potential differences in 
loading and/or transfer.
Adrenomedullin (AM), angiotensin Receptor 1 (AT1-R), bone morphogenetic protein-2 (BMP-2), c-fos, corin, 
ET-1, endothelin Receptor Type A (EDNRA), interleukin 6 (IL6), L-type calcium channel α1c-subunit, osteo-
pontin, sarco/endoplasmic reticulum Ca2+-ATPase 2a (Serca2a), transforming growth factor β1 (TGFβ1), TGFβ2, 
xanthine dehydrogenase and 18 S mRNA levels were measured by RT-PCR using TaqMan chemistry on an ABI 
7700 Sequence Detection System (Applied Biosystems) as previously described75. The sequences of the forward 
(F) and reverse (R) primers as well as the fluorogenic probes (P) for RNA detection are shown in Supplementary 
Tables S3. The results were normalized to 18S RNA quantified from the same samples.
Statistical analysis. Statistical analysis for RNA and protein measurements was performed by One-way 
Analysis of variance (ANOVA) followed by LSD (least significant difference) post hoc for multiple comparisons. 
A value of P < 0.05 was considered statistically significant. The results are expressed as mean±SEM.
DNA microarray analysis. The quality and integrity of the isolated RNA was monitored by gel electropho-
resis. Total RNA (n = 5 biological replicates in each group) was used as a template for synthesizing cDNA and 
for making biotinylated cRNA according to the manufacturer’s instructions (Affymetrix, Santa Clara, CA) as 
previously described76. Briefly, cDNA was reverse-transcripted from 2 μg of total RNA with a T7-(dT)24-primer 
by means of the One-cycle cDNA synthesis kit (Affymetrix). The DNA was purified using the GeneChip Sample 
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Cleanup Module (Qiagen). The cRNA was prepared and biotin-labeled with in vitro transcription (Affymetrix) 
and fragmented before hybridization. The biotinylated cRNA was hybridized to the GeneChip Rat Expression 
Set 230_2.0 Arrays, which represents approximately 30,000 rat transcripts. After hybridization, GeneChips were 
washed and stained with streptavidin-phycoerythrin (Molecular Probes). Staining signal was amplified by bioti-
nylated anti-streptavidin (Vector Laboratories) and the second staining with streptavidin-phycoerythrin was 
conducted using the Affymetrix Fluidics station according to the standard protocol. A GeneChip Scanner 3000 
with GeneChip Operating Software (GCOS) v. 1.2 (Affymetrix) was used in scanning. Affymetrix CEL files were 
imported into GeneSpringTM GX 12.6 software (Agilent Technologies) and Robust Multichip Average (RMA) 
normalization was performed. Genes were defined as differentially expressed if the fold change was at least 
2.0-fold and statistically significant (P < 0.05, One-way ANOVA and Benjamini and Hochberg false discovery 
rate).
IPA pathway analysis of differentially expressed genes. Differentially expressed genes (absolute 
fold-change >1.5; P < 0.05) and their corresponding expression values were uploaded into the Ingenuity Pathway 
Analysis (IPA) software (Qiagen, Redwood City, CA, USA), and a core analysis was performed separately for 
each timepoint. The following parameters were used: core analysis, reference set user-defined (i.e., only the set of 
differentially expressed genes by GeneSpring-software mapped to the IPA database), direct and indirect relation-
ships included, endogenous chemicals included, confidence = experimentally observed.
Next, IPA-software was used to analyze significant associations of biological functions, diseases and 
well-documented canonical pathways in the Ingenuity Pathway Knowledge database and the differentially 
expressed genes (Supplementary Dataset 1). The IPA-analysis calculates whether there is an over-representation 
of significantly up- or down-regulated genes and a particular functional annotation/canonical pathway compared 
to what is expected by chance alone measured by using Fischer’s exact test. Benjamini–Hochberg procedure was 
used for multiple testing corrections. An activation z-score was generated for each functional category. This pro-
vides a prediction of activation (a positive z-score) or inhibition (negative z-score) of each function annotation. 
Z-scores ≥2 or ≤−2 indicate statistically significant activation or inhibition, respectively. The entries that had a 
-Log(P-value) and an absolute z-score value 2 were considered significant. In addition, an IPA-analysis was per-
formed to identify upstream transcriptional regulators that were involved in the stretch activated response at each 
time point and the activation Z-score was used to predict whether they were likely to be activated or inhibited in 
order to obtain the observed changes in gene expression in the datasets.
MicroRNA analysis. MicroRNA array analysis was done by using miRCURY LNATM Array microRNA pro-
filing services (Exiqon, Vedbaek, Denmark). The sample quality of total RNAs from three samples of both the 
controls and the stretched samples at each time point was assessed using Bioanalyser 2100 (Agilent), and those 
RNA integrity number (RIN) values that were greater than 7.6. Samples (n = 3 biological replicates in all time-
points in all groups except n = 2 at 1-hour time point) were labeled with miRCURY LNATM Hy3TM/Hy5TM Power 
labeling kit and hybridized on the miRCURY LNATM Array (v.10.0) probes based on miRBase 11.0 annotation. 
Quantified signals were normalized using the global Locally WEighted Scatterplot Smoothing (LOWESS) regres-
sion algorithm. MicroRNAs were defined as differentially expressed by using two-tailed t-test (P < 0.05) for com-
paring experimental groups of I) 1, 4 and 12 hours, and II) 24 and 48 hours of stretch against their own control.
Integration of miRNA and mRNA expression data. To identify potential miRNA-mRNA interactions, 
we correlated differentially regulated miRNAs at each timepoint (Supplementary Datafile 5) with observed gene 
expression differences at the same or at a later timepoint (Supplementary Datafile 1), and then these were com-
pared with experimentally demonstrated targets of the miRNA using the microRNA Target Filter of IPA software. 
This analysis provides experimentally validated interactions from TarBase and miRecords, as well as predicted 
microRNA-mRNA interactions from TargetScan and a large number of microRNA-related findings from the 
peer-reviewed literature.
Data availability. Gene expression and miRNA profiling data are publicly available on Gene Expression 
Omnibus database GEO, http://www.ncbi.nlm.nih.gov/geo/) under the GEO IDs: GSE107551 (gene expression 
data) and GSE107380 (miRNA expression data).
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